Article info
Clinical science
Management of severe and refractory Mooren's ulcers with rituximab
- Correspondence to Professor Eric E Gabison, Cornea and External Disorders, Cataract and Refractive Surgery Department, Hôpital Bichat and Fondation A. de Rothschild, Université Paris VII, Diderot, Paris, France; egabison{at}for.paris
Citation
Management of severe and refractory Mooren's ulcers with rituximab
Publication history
- Received April 6, 2016
- Revised June 7, 2016
- Accepted July 3, 2016
- First published July 22, 2016.
Online issue publication
April 18, 2017
Article Versions
- Previous version (18 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/